| ID | Sequence | Length | GC content |
|---|---|---|---|
| GCUGCGGCUCAGCUGAUAAUUGAAGGAACCCGGAGCCGCCGCCGCCGCG… | 9998 nt | 0.4204 | |
| GCUGCGGCUCAGCUGAUAAUUGAAGGAACCCGGAGCCGCCGCCGCCGCG… | 10022 nt | 0.4202 | |
| GGGAGAGACGCUCGAGGGCGGCCGCGGCCGGAGGGACCGGGGCCUGGCG… | 5951 nt | 0.3920 | |
| ACCCGCACACUUUCAAUGGGAUAGAAGGGACUCCAAAAGUGAAUGGUAG… | 5961 nt | 0.3862 | |
| GCUGCGGCUCAGCUGAUAAUUGAAGGAACCCGGAGCCGCCGCCGCCGCG… | 6052 nt | 0.3919 | |
| GCUGCGGCUCAGCUGAUAAUUGAAGGAACCCGGAGCCGCCGCCGCCGCG… | 9875 nt | 0.4201 |
The protein encoded by this gene is an E3 ubiquitin-protein ligase involved in the degradation of the p19ARF/ARF isoform of CDKN2A, a tumor suppressor. The encoded protein also plays a role in the DNA damage response by regulating the stability of USP7, which regulates tumor suppressor p53. [provided by RefSeq, Jan 2017]
A study in mice demonstrated that chronic methamphetamine administration significantly dysregulates the ubiquitin-mediated proteolysis pathway in cortical microglia, with the TRIP12 being identified as one of the many components within this pathway that is significantly dysregulated [Oladapo et al. DOI:10.3390/Ijms26020649].